As it expands its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx.
Comments
(._.)
There's nothing here…
As it expands its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx.